TJ191
TJ191 is a selective small-molecule agent designed to target and eliminate malignant T-cell leukemia/lymphoma cells characterized by low expression of TβRIII. Its application in both in vitro and in vivo research models supports its investigation as a potential therapeutic strategy for specific T-cell malignancies.
Product Specifications
CAS Number
1522415-97-9
Product Name Alternative
MT-2, inhibit, JURKAT, PMBC, MOLT-3, MOLT-4, HSB-2, Inhibitor, Apoptosis, cancer, C8166, CEM, TJ191, TJ-191, TJ 191, SUP-T1
Field of Research
Cell Biology
Purity
99.28% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:2.5 mg/mL (9.79 mM) ; DMSO:55 mg/mL (215.37 mM)
Smiles
CCCCCCCc1cc (C (=O) OC) c (N) s1
Molecular Formula
C13H21NO2S
Molecular Weight
255.38
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6145985-01 0.1 mL
ARR3 (Arrestin-C, Cone Arrestin, C-arrestin, cArr, Retinal Cone Arrestin-3, X-arrestin, ARRX, CAR) (FITC)
Sign In for Pricing
View Details MBS6145985-02 5x 0.1 mL
ARR3 (Arrestin-C, Cone Arrestin, C-arrestin, cArr, Retinal Cone Arrestin-3, X-arrestin, ARRX, CAR) (FITC)
Sign In for Pricing
View Details